Research on the drug Alflutop for joint pain and osteoarthritis

Alflutop reduces pain and stiffness in the joints, improves the functional state of the joints, reduces the daily need for NSAIDs, and improves the quality of life of patients.​

1. Multicenter blind randomized placebo-controlled study of the symptom- and structural-modifying effect of the drug Alflutop in patients with osteoarthritis of the knee joints. Report 1 – assessment of the symptom-modifying effect of the drug, 2013 L.I. Alekseeva, E.P. Sharapova, E.A. Taskina, N.V. Chichasova, G.R. Imametdinova, N.A. Shostak, N.G. Pravdyuk, L.M. Denisov

DOWNLOAD PDF

2. Multicenter blind randomized placebo-controlled study of the symptom- and structure-modifying effect of the drug Alflutop in patients with osteoarthritis of the knee joints. Report 2 – assessment of the structure-modifying effect of the drug, 2014 L.I. Alekseeva, E.P. Sharapova, E.A. Taskina, N.V. Chichasova, G.R. Imametdinova, N.A. Shostak, N.G. Pravdyuk, L.M. Denisov

DOWNLOAD PDF

3. The role of inflammation and assessment of the chondroprotective effect of Alflutop in patients with osteoarthritis according to magnetic resonance imaging of the knee joint, 2003. Korshunov N.I., Marasaev V.V., Baranova E.Ya., Parusova N.I., Lutskova L.M.

DOWNLOAD PDF

The Law of Ukraine "On Personal Data Protection" establishes basic requirements for the collection, storage and processing of personal data. Informed consent of the patient involves the collection, transfer, use and storage of the patient's personal data.

INFORMED CONSENT to the processing and transfer of personal data

I consent to the processing of my personal data (i.e., the performance of actions related to the collection, registration, accumulation, storage, adaptation, modification, renewal, updating, use and dissemination (transfer), depersonalization and destruction, as well as the performance of other actions related to the processing of my personal data. The personal data provided by me may be distributed and transferred, including to healthcare institutions of foreign countries, state authorities and local self-government bodies, as well as to other persons determined by the owner/manager independently.
I agree that such transfer of my personal data will not require separate consent or notification to me.